{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:46:55Z","timestamp":1765234015747,"version":"3.41.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,3]]},"DOI":"10.7759\/cureus.87242","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T16:58:17Z","timestamp":1751561897000},"source":"Crossref","is-referenced-by-count":1,"title":["Unequal Burden: Racial Differences in Mortality, Complications, and Resource Utilization in Immune Thrombocytopenia Hospitalizations"],"prefix":"10.7759","author":[{"given":"Tijin","family":"Mathew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa M","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George M","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.78gr.10005","article-title":"Immune thrombocytopenia: no longer 'idiopathic'","volume":"78","author":"McCrae K","year":"2011","unstructured":"McCrae K. Immune thrombocytopenia: no longer 'idiopathic'. Cleve Clin J Med. 2011, 78:358-73. 10.3949\/ccjm.78gr.10005","journal-title":"Cleve Clin J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert C","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, et al.. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019, 3:3829-66. 10.1182\/bloodadvances.2019000966","journal-title":"Blood Adv"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2022.11.022","article-title":"Current approaches for the diagnosis and management of immune thrombocytopenia","volume":"108","author":"Gafter-Gvili A","year":"2023","unstructured":"Gafter-Gvili A. Current approaches for the diagnosis and management of immune thrombocytopenia. Eur J Intern Med. 2023, 108:18-24. 10.1016\/j.ejim.2022.11.022","journal-title":"Eur J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-020-03923-x","article-title":"Intracranial hemorrhage in primary immune thrombocytopenia (ITP): 20\u00a0years' experience in pediatrics","volume":"180","author":"Elalfy MS","year":"2021","unstructured":"Elalfy MS, Eltonbary KY, El Ghamry IR, et al.. Intracranial hemorrhage in primary immune thrombocytopenia (ITP): 20\u00a0years' experience in pediatrics. Eur J Pediatr. 2021, 180:1545-52. 10.1007\/s00431-020-03923-x","journal-title":"Eur J Pediatr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2015.1.237","article-title":"Bleeding complications in immune thrombocytopenia","volume":"2015","author":"Arnold DM","year":"2015","unstructured":"Arnold DM. Bleeding complications in immune thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2015, 2015:237-42. 10.1182\/asheducation-2015.1.237","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05249-8","article-title":"Trends in outcomes and racial disparities in adult hospitalizations for immune thrombocytopenia over a decade","volume":"102","author":"Litvin R","year":"2023","unstructured":"Litvin R, Dasgupta M, Deenadayalan V, et al.. Trends in outcomes and racial disparities in adult hospitalizations for immune thrombocytopenia over a decade. Ann Hematol. 2023, 102:1677-86. 10.1007\/s00277-023-05249-8","journal-title":"Ann Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2014.2214","article-title":"Influence of the American Society of Hematology guidelines on the management of newly diagnosed childhood immune thrombocytopenia","volume":"168","author":"Schultz CL","year":"2014","unstructured":"Schultz CL, Mitra N, Schapira MM, Lambert MP. Influence of the American Society of Hematology guidelines on the management of newly diagnosed childhood immune thrombocytopenia. JAMA Pediatr. 2014, 168:e142214. 10.1001\/jamapediatrics.2014.2214","journal-title":"JAMA Pediatr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2021.1923469","article-title":"Prevalence of primary immune thrombocytopenia and related healthcare resource utilization among Texas Medicaid beneficiaries","volume":"37","author":"Liang Y","year":"2021","unstructured":"Liang Y, Rascati K, Richards K. Prevalence of primary immune thrombocytopenia and related healthcare resource utilization among Texas Medicaid beneficiaries. Curr Med Res Opin. 2021, 37:1315-22. 10.1080\/03007995.2021.1923469","journal-title":"Curr Med Res Opin"},{"key":"ref9","unstructured":"Immune thrombocytopenia. (2022). Accessed. October 10, 2022: https:\/\/rarediseases.org\/rare-diseases\/immune-thrombocytopenia\/."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07615.x","article-title":"Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database","volume":"145","author":"Schoonen WM","year":"2009","unstructured":"Schoonen WM, Kucera G, Coalson J, et al.. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol. 2009, 145:235-44. 10.1111\/j.1365-2141.2009.07615.x","journal-title":"Br J Haematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21500","article-title":"Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura","volume":"84","author":"Danese MD","year":"2009","unstructured":"Danese MD, Lindquist K, Gleeson M, Deuson R, Mikhael J. Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura. Am J Hematol. 2009, 84:631-5. 10.1002\/ajh.21500","journal-title":"Am J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2009.08.004","article-title":"Chronic immune thrombocytopenia in adults: epidemiology and clinical presentation","volume":"23","author":"Fogarty PF","year":"2009","unstructured":"Fogarty PF. Chronic immune thrombocytopenia in adults: epidemiology and clinical presentation. Hematol Oncol Clin North Am. 2009, 23:1213-21. 10.1016\/j.hoc.2009.08.004","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref13","article-title":"Racial and insurance status disparities in patient safety indicators among hospitalized patients","volume":"26","author":"Shen JJ","year":"2016","unstructured":"Shen JJ, Cochran CR, Mazurenko O, Moseley CB, Shan G, Mukalian R, Neishi S. Racial and insurance status disparities in patient safety indicators among hospitalized patients. Ethn Dis. 2016, 26:443-52.","journal-title":"Ethn Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23275","article-title":"Bleeding and mortality outcomes in ITP clinical trials: a review of thrombopoietin mimetics data","volume":"87","author":"Altomare I","year":"2012","unstructured":"Altomare I, Wasser J, Pullarkat V. Bleeding and mortality outcomes in ITP clinical trials: a review of thrombopoietin mimetics data. Am J Hematol. 2012, 87:984-7. 10.1002\/ajh.23275","journal-title":"Am J Hematol"},{"key":"ref15","unstructured":"PDSA E-news. November 30, 2023. (2023). Accessed: June 2, 2025: https:\/\/pdsa.org\/2023-enews\/2303-pdsa-enews-113023."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001898","article-title":"Impact of platelet transfusion thresholds on outcomes of patients with sepsis: analysis of the MIMIC-IV database","volume":"57","author":"Zhou W","year":"2022","unstructured":"Zhou W, Fan C, He S, Chen Y, Xie C. Impact of platelet transfusion thresholds on outcomes of patients with sepsis: analysis of the MIMIC-IV database. Shock. 2022, 57:486-93. 10.1097\/SHK.0000000000001898","journal-title":"Shock"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S123631","article-title":"Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006-2012","volume":"13","author":"An R","year":"2017","unstructured":"An R, Wang PP. Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006-2012. Vasc Health Risk Manag. 2017, 13:15-21. 10.2147\/VHRM.S123631","journal-title":"Vasc Health Risk Manag"},{"key":"ref18","unstructured":"Clinical Classifications Software Refined (CCSR) for ICD-10-CM Diagnoses. (2023). Accessed. July 3, 2025: http:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/ccsr\/dxccsr.jsp."},{"key":"ref19","unstructured":"Introduction to the HCUP National Inpatient Sample (NIS), 2020. (2022). Accessed. July 3,2025: https:\/\/www.hcup-us.ahrq.gov\/db\/nation\/nis\/NISIntroduction2020.pdf."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/383543-unequal-burden-racial-differences-in-mortality-complications-and-resource-utilization-in-immune-thrombocytopenia-hospitalizations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T16:58:19Z","timestamp":1751561899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/383543-unequal-burden-racial-differences-in-mortality-complications-and-resource-utilization-in-immune-thrombocytopenia-hospitalizations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.87242","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,3]]}}}